X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs FRESENIUS KABI ONCO. - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH FRESENIUS KABI ONCO. STERLING BIOTECH/
FRESENIUS KABI ONCO.
 
P/E (TTM) x -1.8 22.1 - View Chart
P/BV x 0.1 3.1 2.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
FRESENIUS KABI ONCO.
Mar-13
STERLING BIOTECH/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs11176 6.0%   
Low Rs379 4.3%   
Sales per share (Unadj.) Rs26.837.7 71.1%  
Earnings per share (Unadj.) Rs-15.05.1 -293.7%  
Cash flow per share (Unadj.) Rs-5.56.7 -81.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.942.5 129.0%  
Shares outstanding (eoy) m267.87158.23 169.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 7.7%   
Avg P/E ratio x-0.525.0 -1.9%  
P/CF ratio (eoy) x-1.318.9 -6.7%  
Price / Book Value ratio x0.13.0 4.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86220,135 9.2%   
No. of employees `0001.41.2 117.5%   
Total wages/salary Rs m547703 77.8%   
Avg. sales/employee Rs Th5,303.35,176.2 102.5%   
Avg. wages/employee Rs Th403.8610.4 66.2%   
Avg. net profit/employee Rs Th-2,959.0699.6 -423.0%   
INCOME DATA
Net Sales Rs m7,1815,963 120.4%  
Other income Rs m4318 236.7%   
Total revenues Rs m7,2235,981 120.8%   
Gross profit Rs m9471,430 66.2%  
Depreciation Rs m2,543258 986.1%   
Interest Rs m4,377-26 -16,835.0%   
Profit before tax Rs m-5,9311,216 -487.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m-1,924342 -562.3%   
Profit after tax Rs m-4,007806 -497.1%  
Gross profit margin %13.224.0 55.0%  
Effective tax rate %32.428.1 115.3%   
Net profit margin %-55.813.5 -412.8%  
BALANCE SHEET DATA
Current assets Rs m14,3355,102 281.0%   
Current liabilities Rs m49,8092,385 2,088.1%   
Net working cap to sales %-494.045.6 -1,084.6%  
Current ratio x0.32.1 13.5%  
Inventory Days Days403150 268.9%  
Debtors Days Days171113 150.6%  
Net fixed assets Rs m55,4325,148 1,076.8%   
Share capital Rs m268158 169.3%   
"Free" reserves Rs m13,9356,556 212.6%   
Net worth Rs m14,7016,732 218.4%   
Long term debt Rs m9,478952 995.4%   
Total assets Rs m73,98810,388 712.2%  
Interest coverage x-0.4-45.8 0.8%   
Debt to equity ratio x0.60.1 455.8%  
Sales to assets ratio x0.10.6 16.9%   
Return on assets %0.57.5 6.7%  
Return on equity %-27.312.0 -227.6%  
Return on capital %-6.414.6 -44.0%  
Exports to sales %25.974.5 34.8%   
Imports to sales %0.224.8 0.7%   
Exports (fob) Rs m1,8604,441 41.9%   
Imports (cif) Rs m121,477 0.8%   
Fx inflow Rs m1,8605,298 35.1%   
Fx outflow Rs m251,772 1.4%   
Net fx Rs m1,8353,525 52.0%   
CASH FLOW
From Operations Rs m1,7191,274 134.9%  
From Investments Rs m-3,148-1,204 261.4%  
From Financial Activity Rs m1,426-196 -727.2%  
Net Cashflow Rs m-3-126 2.7%  

Share Holding

Indian Promoters % 33.9 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 9.9 9.6 103.1%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 9.1 431.9%  
Shareholders   21,482 42,599 50.4%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   ABBOTT INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 16, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SHASUN PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS